Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Differential sensitization by orobol in proliferating and quiescent human ovarian carcinoma cells
Autore:
Shiotsuka, S; Isonishi, S;
Indirizzi:
Jikei Univ, Sch Med, Dept Obstet Gynecol, Minato Ku, Tokyo 105, Japan Jikei Univ Tokyo Japan 105 t Obstet Gynecol, Minato Ku, Tokyo 105, Japan
Titolo Testata:
INTERNATIONAL JOURNAL OF ONCOLOGY
fascicolo: 2, volume: 18, anno: 2001,
pagine: 337 - 342
SICI:
1019-6439(200102)18:2<337:DSBOIP>2.0.ZU;2-D
Fonte:
ISI
Lingua:
ENG
Soggetto:
MESSENGER-RNA EXPRESSION; RAT-LIVER; GLUTATHIONE DEPLETION; CYTO-TOXICITY; CISPLATIN; APOPTOSIS; KINASE; PHOSPHATIDYLINOSITOL; SENSITIVITY; RESISTANCE;
Keywords:
platinum agents; phosphatidylinositol 4-kinase; drug sensitivity; orobol;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Life Sciences
Citazioni:
31
Recensione:
Indirizzi per estratti:
Indirizzo: Shiotsuka, S Jikei Univ, Sch Med, Dept Obstet Gynecol, Minato Ku, 3-25-8 Nishi Shimbashi, Tokyo 105, Japan Jikei Univ 3-25-8 Nishi Shimbashi Tokyo Japan 105 105, Japan
Citazione:
S. Shiotsuka e S. Isonishi, "Differential sensitization by orobol in proliferating and quiescent human ovarian carcinoma cells", INT J ONCOL, 18(2), 2001, pp. 337-342

Abstract

The object of this study was to determine how phosphatidylinositol (PI) signaling pathway is involved in the regulation of cisplatin (DDP) sensitivity. Clonogenic survival assay was used to determine the effect of orobol, a potent PI4-kinase inhibitor, on DDP sensitivity in human ovarian carcinoma 2008 cells. Orobol enhanced sensitivity to DDP in 2008 cells by a factor of2.1+/-0.4 (SD)-fold (N=3; P<.001). Sensitization was specific for proliferating cells. Orobol did not alter DDP sensitivity in quiescent cells. Orobol also produced a 2-fold increase in sensitivity to DDP in proliferating 2008/C13*5.25 DDP-resistant variants. Our studies indicated that orobol-induced sensitization depended on the presence of proliferating cells in G2+M phase of the cell cycle. Orobol did not modulate the cellular accumulation ofDDP nor did it alter the CdCl2 sensitivity, suggesting that the amount of platinated-DNA was not changed by orobol treatment. However, orobol rendered 2008 cells resistant to rhodamin 123 by 5.7+/-1.7 (SD)-fold (N=3, P<0.01). Since sensitivity to rhodamin 123 is indicative of mitochondrial membranepotential, these results imply that mitochondrial alterations may be an important component of the orobol sensitization effect in these cells.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 03/04/20 alle ore 10:57:07